drugset / Trial / NCT00806169
Combined Triple Therapy in Diabetic Retinopathy (DRP)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with macular edema due to diabetic retinopathy.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-10
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |
| Subject | Triamcinolone | Other / unclassified | 8 mg | Intravitreal |